drugset / Trial / NCT04601675
Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is to evaluate the visual outcome and prognostic factors after intraocular injections of Ranibizumab or combination of Ranibizumab And Dexamethasone under pro re nata treatment regimen for Diabetic Macular Edema patients.
Timeline
- Start
- 2020-10-31
- Primary completion
- 2021-03-01
- Completion
- 2021-09-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | — | Intravitreal |
| Subject | Ranibizumab | Monoclonal antibody | — | Other |